Company Announcements

H1 2020 Pillar 3 Supplement - Appendix

Source: RNS
RNS Number : 8743X
NatWest Group plc
03 September 2020
 

NatWest Group plc

3 September 2020

 

 

 

NatWest Group plc H1 2020 Pillar 3 Supplement (Appendix)

NatWest Holdings Group H1 2020 Pillar 3 Supplement (Appendix)

 

NatWest Group plc and NatWest Holdings Group today publish Appendices to their H1 2020 Pillar 3 Supplement (Covid-19 information), which are available on the Natwest Group website at

https://investors.natwestgoup.com/reports-archive/2020.aspx

 

For further information, please contact

 

NatWest Group Investor Relations

Investor.relations@natwest.com

+44 207 672 1758

 

NatWest Group Media Relations

+44 131 523 4205

 

3 September 2020

 

 

LEI:

2138005O9XJIJN4JPN90 - NatWest Group plc

213800GDQMMREYFLQ454 - NatWest Holdings Limited

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCDLLFBBKLXBBQ